Chimeric antigen receptor-modified T cells against several target antigens in multiple myeloma

被引：1
|
作者：
Chang, Lung-Ji [1 ]
Liu, Yuchen [1 ]
Kuo, Hao-Hsiang [1 ]
Tsao, Shih-Ting [1 ]
Moreb, Jan S. [1 ]
机构：
[1] Univ Florida, Gainesville, FL USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-3149
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3149
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Adoptive Therapy With Chimeric Antigen Receptor-Modified T Cells of Defined Subset Composition
    Riddell, Stanley R.
    Sommermeyer, Daniel
    Berger, Carolina
    Liu, Lingfeng
    Balakrishnan, Ashwini
    Salter, Alex
    Hudecek, Michael
    Maloney, David G.
    Turtle, Cameron J.
    CANCER JOURNAL, 2014, 20 (02): : 141 - 144
  • [22] Interleukin-armed chimeric antigen receptor-modified T cells for cancer immunotherapy
    Y Huang
    D Li
    D-Y Qin
    H-F Gou
    W Wei
    Y-S Wang
    Y-Q Wei
    W Wang
    Gene Therapy, 2018, 25 : 192 - 197
  • [23] Improving expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients
    不详
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 90 (02) : 198 - 198
  • [24] Strategies to Improve the Clinical Performance of Chimeric Antigen Receptor-Modified T Cells for Cancer
    Zhang, Qing
    Li, Huizhong
    Yang, Jie
    Li, Liantao
    Zhang, Baofu
    Li, Jia
    Zheng, Junnian
    CURRENT GENE THERAPY, 2013, 13 (01) : 65 - 70
  • [25] Synergistic Antitumor Effects of Chimeric Antigen Receptor-Modified T Cells and Oncolytic Virotherapy
    Wang, Xingbing
    Gottschalk, Stephen
    Song, Xiao-Tong
    BLOOD, 2014, 124 (21)
  • [26] Nonviral RNA chimeric antigen receptor-modified T cells in patients with Hodgkin lymphoma
    Svoboda, Jakub
    Rheingold, Susan R.
    Gill, Saar I.
    Grupp, Stephan A.
    Lacey, Simon F.
    Kulikovskaya, Irina
    Suhoski, Megan M.
    Melenhorst, J. Joseph
    Loudon, Brandon
    Mato, Anthony R.
    Nasta, Sunita Dwivedy
    Landsburg, Daniel J.
    Youngman, Matthew R.
    Levine, Bruce L.
    Porter, David L.
    June, Carl H.
    Schuster, Stephen J.
    BLOOD, 2018, 132 (10) : 1022 - 1026
  • [27] Anti-CD138 chimeric antigen receptor-modified T cell therapy for multiple myeloma with extensive extramedullary involvement
    Tian, Chen
    Yang, Hongliang
    Zhu, Lei
    Zhang, Qing
    Cao, Zeng
    Zhang, Yizhuo
    ANNALS OF HEMATOLOGY, 2017, 96 (08) : 1407 - 1410
  • [28] Anti-CD138 chimeric antigen receptor-modified T cell therapy for multiple myeloma with extensive extramedullary involvement
    Chen Tian
    Hongliang Yang
    Lei Zhu
    Qing Zhang
    Zeng Cao
    Yizhuo Zhang
    Annals of Hematology, 2017, 96 : 1407 - 1410
  • [29] Allogeneic chimeric antigen receptor T-cells and multiple myeloma
    Malard, Florent
    HEMATOLOGIE, 2021, 27 : 13 - 18
  • [30] Chimeric Antigen Receptor T Cells in Myeloma
    Shimabukuro-Vornhagen, Alexander
    Schloesser, Hans A.
    von Bergwelt-Baildon, Michael S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (02): : 193 - 194
12345